Today: 8 February 2026
Subscribe
Browse Category

NASDAQ:BLLN News 24 November 2025 - 31 December 2025

BillionToOne (BLLN) stock slides 4% in thin year-end trade as investors look to January catalysts

BillionToOne (BLLN) stock slides 4% in thin year-end trade as investors look to January catalysts

BillionToOne shares fell 4% to $81.61 in thin trading on the last day of 2025, underperforming diagnostics peers. The company last reported third-quarter revenue of $83.5 million, up 117% year over year, and forecast full-year revenue of $293 million to $299 million. No new company disclosures appeared Wednesday. Management is set to present at the J.P. Morgan Healthcare Conference on Jan. 12.
31 December 2025
··
BillionToOne (BLLN) Stock Update: Friday Rally, Analyst Price Targets, and the Next Catalysts Before Nasdaq Reopens

BillionToOne (BLLN) Stock Update: Friday Rally, Analyst Price Targets, and the Next Catalysts Before Nasdaq Reopens

BillionToOne shares closed at $89.30 Friday, up 3.43%, after trading between $85.62 and $89.99. The stock remains 35% below its 52-week high, with a market cap near $4.09 billion. Analyst coverage skews positive, with a “Moderate Buy” consensus and targets above current levels. The company’s Q3 revenue rose 117% to $83.5 million, with net income of $1.5 million.
28 December 2025
··
BillionToOne Stock (NASDAQ: BLLN) News: Weekend Market Wrap, Analyst Targets, and What to Watch Before Monday’s Open

BillionToOne Stock (NASDAQ: BLLN) News: Weekend Market Wrap, Analyst Targets, and What to Watch Before Monday’s Open

BillionToOne shares closed Friday at $89.30, up 3.43%, after swinging between $85.62 and $89.99 in a thin, holiday-shortened session. The stock remains about 49% above its $60 IPO price but trades 36% below its 52-week high. No new company filings or press releases surfaced in the past 48 hours. Recent coverage centers on analyst ratings and index inclusion, not fresh corporate news.
28 December 2025
·
BillionToOne Stock (NASDAQ: BLLN) Rises Into the Weekend as Analyst Targets Point Higher — What Investors Need to Know Before Monday

BillionToOne Stock (NASDAQ: BLLN) Rises Into the Weekend as Analyst Targets Point Higher — What Investors Need to Know Before Monday

BillionToOne (NASDAQ: BLLN) closed Friday at $89.30, up 3.43%, after a volatile session in thin post-holiday trading. No major company news drove the move, with analysts maintaining a “Moderate Buy” rating and an average 12-month target of $137.83. Broader U.S. markets ended flat to slightly lower. BLLN began trading publicly in early November.
27 December 2025
··
BillionToOne Stock (NASDAQ: BLLN) News, Forecasts, and Analyst Outlook for December 22, 2025

BillionToOne Stock (NASDAQ: BLLN) News, Forecasts, and Analyst Outlook for December 22, 2025

BillionToOne, Inc. (NASDAQ: BLLN) is still in the “fresh IPO” phase where price discovery happens in public—loudly. On December 22, 2025, the molecular diagnostics company’s shares were trading at $97.36, down about 5.1% on the session, after opening above $103 and swinging through a $96.61–$103.85 intraday range. There wasn’t a new company press release dated today that materially changed the story. Instead, BLLN’s move looks like part of the normal churn that follows a high-profile debut: early enthusiasm, analyst initiations, earnings/guidance digestion, and then a tug-of-war between “this could be huge” and “but how much is already priced in?” Below
22 December 2025
·
BLLN Stock Today: BillionToOne Closes Near Highs as Post‑IPO Rally Accelerates (Nov. 24, 2025)

BLLN Stock Today: BillionToOne Closes Near Highs as Post‑IPO Rally Accelerates (Nov. 24, 2025)

BillionToOne (NASDAQ: BLLN) continued its powerful post‑IPO run on Monday, with shares of the precision diagnostics company closing near their recent highs and extending a rally that has already doubled the stock from its offering price earlier this month. As investors hunt for high‑growth healthcare names with a credible path toward profitability, BLLN has quickly become one of Wall Street’s most closely watched new listings. BLLN stock today: price, move, and key stats (Nov. 24, 2025) As of Monday’s close on November 24, 2025, BillionToOne stock traded with the following profile: StockAnalysis+1 At Monday’s close, BLLN trades just over 100%
24 November 2025
··

Stock Market Today

Disney stock ends week higher after Friday bounce — what to watch for DIS next week

Disney stock ends week higher after Friday bounce — what to watch for DIS next week

7 February 2026
Disney shares closed up 3.6% at $108.70 Friday, recovering from earlier losses as U.S. stocks rallied and the Dow topped 50,000. Investors are watching Super Bowl streaming economics and Disney’s CEO transition, with Josh D’Amaro set to take over at the March 18 meeting. Disney reported quarterly revenue of $25.98 billion and adjusted EPS of $1.63, while segment operating income fell 9% to $4.6 billion.
Novo Nordisk stock: Class B shares face Monday test after FDA squeeze forces Hims to pull $49 Wegovy copycat

Novo Nordisk stock: Class B shares face Monday test after FDA squeeze forces Hims to pull $49 Wegovy copycat

7 February 2026
Novo Nordisk Class B shares closed up 5.3% at 295.50 Danish crowns in Copenhagen after Hims & Hers said it would stop offering a compounded pill version of Wegovy following U.S. regulatory warnings. The move came after Novo called the Hims product “illegal mass compounding” and threatened legal action. Shares had fallen nearly 8% Thursday after Hims launched the pill. Trading resumes Monday.
Go toTop